According to clinical observations, weight loss-induced improvements in glycemia are most likely to occur early in the natural history of T2DM, when obesity-associated IR has caused reversible ß-cell dysfunction, but insulin secretory capacity remains relatively preserved (Schauer et al., 2016; Steven et al., 2016). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.